To further investigate whether the co-mutation and inactivation of RB1 and TP53 would lead to upregulation of ASCL1 which is a lineage transcription factor required for neuron and neuroendocrine differentiation and frequently high expression in approximately 75% of all SCLC subtypes (24). This evidence concerns the gene TP53 and small cell lung carcinoma.